Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	0.67	71.67	71.20
Graham Fair Price	29.93	2.59	1.99
PEG	-28.99	1.77	-2.50
Price/Book	0.18	2.28	2.28
Price/Cash Flow	inf	0.00	46.73
Prices/Earnings	-44.00	131.03	233.99
Price/Sales	-0.49	8.37	8.41
Price/FCF	inf	0.00	46.73
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	7.81	0.46	0.43
Operating Margin	-3.80	0.06	0.06
ROA	83.35	< 0.005	< 0.005
ROE	< 0.005	< 0.005	78.91
ROIC	< 0.005	< 0.005	-4.74
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	0.12	-0.19	-34.70
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.74	-0.06	92.03
EPS QOQ	-0.94	0.74	-21.14
FCF QOQ	< 0.005	0.00	inf
Revenue QOQ	-0.31	-0.02	92.79
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	180.14	167.93	-6.78
Days Sales Outstanding (DSO)	63.58	57.52	-9.53
Inventory Turnover	0.50	0.54	7.27
Debt/Capitalization	0.42	0.43	1.29
Quick Ratio	0.72	0.82	13.94
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	8.50	8.26	-2.86
Cash	0.45	0.59	30.96
Capex	0.00	n.A.	n.A.
Free Cash Flow	0.41	n.A.	n.A.
Revenue	2.30	2.25	-2.20
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.66	1.76	5.95
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	16.35	18.17	11.15
Naive Interpretation	Member

06 - Financial Health · Weak

Rating